Beverly Orsak

4.2k total citations · 3 hit papers
20 papers, 3.2k citations indexed

About

Beverly Orsak is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Beverly Orsak has authored 20 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Hepatology. Recurrent topics in Beverly Orsak's work include Liver Disease Diagnosis and Treatment (17 papers), Diet, Metabolism, and Disease (11 papers) and Pancreatitis Pathology and Treatment (6 papers). Beverly Orsak is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Diet, Metabolism, and Disease (11 papers) and Pancreatitis Pathology and Treatment (6 papers). Beverly Orsak collaborates with scholars based in United States and Ecuador. Beverly Orsak's co-authors include Kenneth Cusi, Romina Lomonaco, Fernando Bril, Fermin O. Tio, Carolina Ortiz‐Lopez, Amy Webb, Joan Hecht, Jean Hardies, Paola Portillo-Sánchez and Diane Biernacki and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Beverly Orsak

20 papers receiving 3.2k citations

Hit Papers

Long-Term Pioglitazone Treatment for Patients With Nonalc... 2015 2026 2018 2022 2016 2015 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
    2016 737 citations Kenneth Cusi, Beverly Orsak et al. Annals of Internal Medicine profile →
  2. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
    2015 393 citations Paola Portillo-Sánchez, Fernando Bril et al. The Journal of Clinical Endocrinology & Metabolism profile →
  3. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
    2019 235 citations Fernando Bril, Diane Biernacki et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly Orsak United States 16 2.8k 1.8k 905 556 546 20 3.2k
Romina Lomonaco United States 25 3.6k 1.3× 2.2k 1.3× 1.1k 1.3× 734 1.3× 710 1.3× 37 4.2k
Celia Darland United States 6 2.2k 0.8× 1.7k 0.9× 601 0.7× 535 1.0× 728 1.3× 7 2.8k
Luis Calzadilla Bertot Australia 16 3.2k 1.1× 1.5k 0.8× 1.6k 1.8× 564 1.0× 378 0.7× 38 3.6k
Diana Barb United States 20 2.8k 1.0× 1.5k 0.8× 938 1.0× 536 1.0× 498 0.9× 31 3.5k
Mara Brizi Italy 9 3.0k 1.1× 1.8k 1.0× 740 0.8× 550 1.0× 591 1.1× 15 3.7k
M. Marietti Italy 8 4.0k 1.4× 1.6k 0.9× 1.5k 1.7× 595 1.1× 975 1.8× 17 4.6k
Elena Buzzetti Italy 17 2.3k 0.8× 989 0.6× 617 0.7× 299 0.5× 753 1.4× 39 2.9k
Carol Sargeant United States 12 3.5k 1.2× 1.7k 0.9× 1.5k 1.7× 851 1.5× 728 1.3× 17 4.2k
L. Miglioli Italy 14 3.4k 1.2× 1.7k 1.0× 1.3k 1.4× 482 0.9× 332 0.6× 27 3.8k
Carolina Ortiz‐Lopez United States 11 1.8k 0.6× 1.1k 0.6× 535 0.6× 391 0.7× 354 0.6× 18 2.1k

Countries citing papers authored by Beverly Orsak

Since Specialization
Citations

This map shows the geographic impact of Beverly Orsak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Orsak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Orsak more than expected).

Fields of papers citing papers by Beverly Orsak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Orsak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Orsak. The network helps show where Beverly Orsak may publish in the future.

Co-authorship network of co-authors of Beverly Orsak

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Orsak. A scholar is included among the top collaborators of Beverly Orsak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Orsak. Beverly Orsak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chen-Pin, Beverly Orsak, Dean L. Kellogg, et al.. (2020). A geriatrics walking clinic improves hemoglobin A1c and timed gait in older veterans with type 2 diabetes. Geriatric Nursing. 42(2). 566–569. 6 indexed citations
2.
Bril, Fernando, Diane Biernacki, Srilaxmi Kalavalapalli, et al.. (2019). Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 42(8). 1481–1488. 235 indexed citations breakdown →
3.
Espinoza, Sara, Beverly Orsak, Cheng‐Ping Wang, et al.. (2019). An Individualized Low-Intensity Walking Clinic Leads to Improvement in Frailty Characteristics in Older Veterans. The Journal of Frailty & Aging. 8(4). 205–209. 6 indexed citations
4.
Espinoza, Sara, Nicolas Musi, Chen-Pin Wang, et al.. (2019). Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults With Prediabetes. The Journals of Gerontology Series A. 75(1). 102–109. 44 indexed citations
5.
Bril, Fernando, Diane Biernacki, Romina Lomonaco, et al.. (2018). Role of Vitamin E for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients with T2DM—A Randomized, Controlled Trial. Diabetes. 67(Supplement_1). 3 indexed citations
6.
Portillo-Sánchez, Paola, Fernando Bril, Romina Lomonaco, et al.. (2018). Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36‐month clinical trial. Journal of Diabetes. 11(3). 223–231. 29 indexed citations
7.
Bril, Fernando, Romina Lomonaco, Beverly Orsak, et al.. (2017). Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2950–2961. 75 indexed citations
8.
Bril, Fernando, Srilaxmi Kalavalapalli, Virginia Clark, et al.. (2017). Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. Clinical Gastroenterology and Hepatology. 16(4). 558–566.e2. 158 indexed citations
9.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 14 indexed citations
10.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 165(5). 305–315. 737 indexed citations breakdown →
11.
Lomonaco, Romina, Fernando Bril, Paola Portillo-Sánchez, et al.. (2016). Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. Diabetes Care. 39(4). 632–638. 116 indexed citations
12.
Bril, Fernando, John J. Sninsky, Arthur M. Baca, et al.. (2015). Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. The Journal of Clinical Endocrinology & Metabolism. 101(2). 644–652. 136 indexed citations
13.
Bril, Fernando, Carolina Ortiz‐Lopez, Romina Lomonaco, et al.. (2015). Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver International. 35(9). 2139–2146. 179 indexed citations
14.
Portillo-Sánchez, Paola, Fernando Bril, Maryann Maximos, et al.. (2015). High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. The Journal of Clinical Endocrinology & Metabolism. 100(6). 2231–2238. 393 indexed citations breakdown →
15.
Maximos, Maryann, Fernando Bril, Romina Lomonaco, et al.. (2014). The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Hepatology. 61(1). 153–160. 152 indexed citations
16.
Bril, Fernando, Romina Lomonaco, Beverly Orsak, et al.. (2013). Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology. 59(6). 2178–2187. 128 indexed citations
17.
Cusi, Kenneth, Zhihui Chang, Romina Lomonaco, et al.. (2013). Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 60(1). 167–174. 193 indexed citations
18.
Ortiz‐Lopez, Carolina, Romina Lomonaco, Beverly Orsak, et al.. (2012). Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes Care. 35(4). 873–878. 196 indexed citations
19.
Lomonaco, Romina, Carolina Ortiz‐Lopez, Beverly Orsak, et al.. (2011). Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 55(5). 1389–1397. 356 indexed citations
20.
Lomonaco, Romina, Carolina Ortiz‐Lopez, Beverly Orsak, et al.. (2011). Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology. 54(3). 837–845. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romina Lomonaco Breakdown of academic impact, for papers by Celia Darland Breakdown of academic impact, for papers by Luis Calzadilla Bertot Breakdown of academic impact, for papers by Diana Barb Breakdown of academic impact, for papers by Mara Brizi Breakdown of academic impact, for papers by M. Marietti Breakdown of academic impact, for papers by Elena Buzzetti Breakdown of academic impact, for papers by Carol Sargeant Breakdown of academic impact, for papers by L. Miglioli Breakdown of academic impact, for papers by Carolina Ortiz‐Lopez
Rankless by CCL
2026